Brief: Glass Lewis Recommends Shareholders Vote The GREEN Proxy FOR ALL MediPharm Director Nominees
13/06/2025 14:31
June 13 (Reuters) - Medipharm Labs Corp LABS.TO: LEADING INDEPENDENT PROXY ADVISOR GLASS LEWIS RECOMMENDS SHAREHOLDERS VOTE THE GREEN PROXY FOR ALL MEDIPHARM DIRECTOR NOMINEES Source text: ID:nGNX54mtT7 Further company coverage: LABS.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue